Cosmetic · Palmitoylated synthetic tetrapeptide
Palmitoyl Tetrapeptide-10
Also known as —
A lipid-modified tetrapeptide whose sequence, solution behaviour and target evidence require verification for reproducible research.
- Length
- 4 amino acids with a palmitoyl group
- Half-life
- Not well characterised
- Mechanism
- The palmitoyl group increases the hydrophobic character of the peptide, potentially affecting membrane association, aggregation and assay availability. A specific receptor target or validated sequence-dependent signalling mechanism is not firmly established from the ingredient designation alone.
- Studied in
- Foundational laboratory characterisation can examine solubility, aggregation, membrane partitioning and cell compatibility before applying a sequence-supported mechanistic assay.
About Palmitoyl Tetrapeptide-10
Palmitoyl Tetrapeptide-10 denotes a four-residue peptide modified with a palmitoyl group, an acyl group derived from the sixteen-carbon fatty acid palmitic acid. The name does not itself disclose the amino-acid sequence, stereochemistry or complete terminal structure. These details must come from the batch specification. A reliable endogenous sequence origin and a clearly documented discovery narrative cannot be assigned without additional structural information and supporting primary literature.
Palmitoylation changes a peptide's physicochemical behaviour but does not establish a biological target. Lipid-modified peptides may associate with membranes, adsorb to laboratory surfaces or form aggregates, depending on their sequence and experimental environment. These properties can influence apparent activity in cell-based assays. Mechanistic work should therefore begin with analytical identity, solution characterisation and compatibility controls rather than borrowing receptor assignments or biological effects reported for other palmitoylated tetrapeptides.
Laboratory notes
- Verify the four-residue sequence, stereochemistry, acylation site and terminal modifications using the supplier's structural specification.
- Assess solvent compatibility and aggregation in the final assay medium; visual clarity alone does not demonstrate molecular dissolution.
- Check peptide recovery from assay vessels and include controls for vehicle effects and nonspecific membrane disruption.
Storage and reconstitution basics: storage guide.
Questions about Palmitoyl Tetrapeptide-10
Does palmitoylation identify a receptor target?
No. It identifies a lipid modification that alters physicochemical properties. Receptor specificity depends on the complete molecular structure and experimental evidence.
Is Palmitoyl Tetrapeptide-10 interchangeable with other palmitoylated tetrapeptides?
No. Different sequences and terminal modifications can produce substantially different binding, stability and assay behaviour.
Why can assay recovery be lower than expected?
Hydrophobic material may adsorb to surfaces, associate with medium components or aggregate. Analytical recovery measurements can help identify these losses.
Is Palmitoyl Tetrapeptide-10 for human use?
No. It is supplied strictly for in-vitro laboratory research and is not for human or animal consumption.
Related research peptides
All products are sold for laboratory research use only. Not for human consumption, not a medicine, not for diagnosing, treating or preventing any condition.